EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieKlinische Studie (Phase II)

Randomized controlled trial of linaclotide in children aged 6−17 years with functional constipation

Carlo Di Lorenzo, Samuel Nurko, Jeffrey S Hyams, Gerardo Rodriguez-Araujo, Cristina Almansa, Valentina Shakhnovich, Miguel Saps, Michael Simon

Journal of Pediatric Gastroenterology and Nutrition · 2024-05 · 78 (5) · 1059-1068

DOI: 10.1002/jpn3.12184 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Pediatric Gastroenterology and Nutrition, online erschienen am 27.03.2024. Verfasst von Carlo Di Lorenzo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Nationwide Children's Hospital, Columbus, Ohio, USA. Hauptthemen laut MEDLINE: Constipation, Peptides, Guanylyl Cyclase C Agonists. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: AbbVie Inc., Ironwood Pharmaceuticals, Inc..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Linaclotide, a guanylate cyclase‐C agonist, was recently approved in the United States for treatment of children 6−17 years old with functional constipation (FC). This study evaluated the safety and efficacy of several linaclotide doses in children 6−17 years old with FC.

Methods

In this multicenter, randomized, double‐blind, placebo‐controlled phase 2 study, 173 children with FC (based on Rome III criteria) were randomized to once‐daily linaclotide (A: 9 or 18 μg, B: 18 or 36 μg, or C: 36 or 72 μg) or placebo in a 1:1:1:1 ratio for 6‐ to 11‐year‐olds (dosage determined by weight: 18 to

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ConstipationPeptidesGuanylyl Cyclase C AgonistsHumansChildAdolescentDouble-Blind MethodFemaleMaleTreatment OutcomeDefecationDose-Response Relationship, DrugGastrointestinal Agents

Stichwörter der Autor:innen

constipationfunctional GI diseasespediatric gastroenterologysmall intestine

Substanzen

linaclotidePeptidesGuanylyl Cyclase C AgonistsGastrointestinal Agents

Autor:innen und Institutionen

  • Nationwide Children's Hospital, Columbus, Ohio, USA.
  • Boston Children's Hospital, Boston, Massachusetts, USA.
  • Connecticut Children's Medical Center, Hartford, Connecticut, USA.
  • AbbVie Inc., North Chicago, Illinois, USA.
  • Janssen Pharmaceutical Companies of Johnson and Johnson, Cambridge, Massachusetts, USA.
  • Ironwood Pharmaceuticals, Inc., Boston, Massachusetts, USA.

Förderung

  • AbbVie Inc.
  • Ironwood Pharmaceuticals, Inc.

Zitieren

APA

Di Lorenzo, C., Nurko, S., Hyams, J. S., Rodriguez-Araujo, G., Almansa, C., Shakhnovich, V., Saps, M., & Simon, M. (2024). Randomized controlled trial of linaclotide in children aged 6−17 years with functional constipation. Journal of Pediatric Gastroenterology and Nutrition, 78(5), 1059-1068. https://doi.org/10.1002/jpn3.12184

Vancouver

Di Lorenzo C, Nurko S, Hyams JS, Rodriguez-Araujo G, Almansa C, Shakhnovich V, et al. Randomized controlled trial of linaclotide in children aged 6−17 years with functional constipation. Journal of Pediatric Gastroenterology and Nutrition. 2024;78(5):1059-1068. doi:10.1002/jpn3.12184

BibTeX
@article{DiLorenzo2024,
  author = {Di Lorenzo, Carlo and Nurko, Samuel and Hyams, Jeffrey S and Rodriguez-Araujo, Gerardo and Almansa, Cristina and Shakhnovich, Valentina and Saps, Miguel and Simon, Michael},
  title = {Randomized controlled trial of linaclotide in children aged 6−17 years with functional constipation},
  journal = {Journal of Pediatric Gastroenterology and Nutrition},
  year = {2024},
  volume = {78},
  number = {5},
  pages = {1059--1068},
  doi = {10.1002/jpn3.12184}
}
Kostenlos starten →